Monthly dosing reduces treatment visits while maintaining established safety and efficacy1,2 Builds on RYBREVANT FASPRO FDA approval to deliver the simplest and fastest ...
Lower kidney function is associated with elevated Alzheimer’s blood biomarkers, raising implications for dementia diagnosis ...
New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT ...
New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO beyond lung ...
People with reduced kidney function may have higher levels of several blood markers commonly used in Alzheimer’s disease research, according to a large new review published in the Journal of the ...
Background Secondary prevention is critical for patients with established atherosclerotic cardiovascular diseases (ASCVD).
Researchers at University of California San Diego School of Medicine have developed a new, easy-to-use blood test score that ...
A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it ...
The Alzheimer’s ‘clock’ could make it easier to treat the disease early, before memory problems appear. A simple blood test might one day serve as a molecular ‘clock’ that predicts not only whether ...
Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. Quest Flow ...
When it comes to cancer, waiting for symptoms may soon be old news. Telehealth company Hims & Hers began offering a blood test this week that screens for a wide range of cancers before warning signs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results